Publications:

Durable response to afatinib in an advanced lung adenocarcinoma patient with an EGFR L858R/G729A compound mutation: a case report.

Annals Of Translational Medicine

Wu, Lige L; Fang, Cheng C; Zhao, Weiqing W; Li, Dong D; Tang, Shuxian S; Li, Xi X; Ji, Mei M

Publication Date: 2022-01

Variant appearance in text: EGFR: G729A

PubMed Link: 35282062

Variant Present in the following documents:

• Main text
• atm-10-02-116.pdf

View BVdb publication page

Efficacy and Safety of Rociletinib Versus Chemotherapy in Patients With EGFR-Mutated NSCLC: The Results of TIGER-3, a Phase 3 Randomized Study.

Jto Clinical And Research Reports

Yang, James Chih-Hsin JC; Reckamp, Karen L KL; Kim, Young-Chul YC; Novello, Silvia S; Smit, Egbert F EF; Lee, Jong-Seok JS; Su, Wu-Chou WC; Akerley, Wallace L WL; Blakely, Collin M CM; Groen, Harry J M HJM; Bazhenova, Lyudmila L; Carcereny Costa, Enric E; Chiari, Rita R; Hsia, Te-Chun TC; Golsorkhi, Tony T; Despain, Darrin D; Shih, Danny D; Popat, Sanjay S; Wakelee, Heather H

Publication Date: 2021-02

Variant appearance in text: EGFR: G729A

PubMed Link: 34589984

Variant Present in the following documents:

• Main text
• main.pdf

View BVdb publication page

Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients.

Nature Communications

Zhang, Yongliang Y; Yao, Yu Y; Xu, Yaping Y; Li, Lifeng L; Gong, Yan Y; Zhang, Kai K; Zhang, Meng M; Guan, Yanfang Y; Chang, Lianpeng L; Xia, Xuefeng X; Li, Lin L; Jia, Shuqin S; Zeng, Qiang Q

Publication Date: 2021-01-04

Variant appearance in text: EGFR: 2186G>C; G729A

PubMed Link: 33397889

Variant Present in the following documents:

• 41467_2020_20162_MOESM6_ESM.xlsx, sheet 1

View BVdb publication page

Next‑generation sequencing‑based detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her‑2 and TP53 mutations in patients with non‑small cell lung cancer.

Molecular Medicine Reports

Jing, Changwen C; Mao, Xuhua X; Wang, Zhuo Z; Sun, Kejing K; Ma, Rong R; Wu, Jianzhong J; Cao, Haixia H

Publication Date: 2018-08

Variant appearance in text: EGFR: 2186G>C; G729A

PubMed Link: 29956783

Variant Present in the following documents:

• Main text
• mmr-18-02-2191.pdf

View BVdb publication page

Analysis of progression-free survival of first-line tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring leu858Arg or exon 19 deletions.

Oncotarget

Kuan, Feng-Che FC; Li, Shih-Hong SH; Wang, Chih-Liang CL; Lin, Meng-Hung MH; Tsai, Ying-Huang YH; Yang, Cheng-Ta CT

Publication Date: 2017-01-03

Variant appearance in text: EGFR: G729A

PubMed Link: 27935868

Variant Present in the following documents:

• oncotarget-08-1343-s001.pdf

View BVdb publication page